心血管

订阅

MedSci主页 / 所有栏目 / 心血管

美国临床内分泌协会：血脂异常管理和动脉粥样硬化预防指南

2012-03-29 广西医科大学第五附院，柳州市人民医院心内科胡世红 Endocr Pract 2012.

指南
关注

2012-03-15 美国临床内分泌医师学会(AACE,American Association of Clinical Endocrinologists) AACE指南分为4个部分：第1部分为绪言，第三世界部分为方法，第3部分为执行纲要，第4部分为证据基础。本译文仅译出了前三部分。原文中有大量表格，译文中从略——译者注 AACE指南.doc

2012-03-15 美国临床内分泌医师学会(AACE,American Association of Clinical Endocrinologists)
AACE指南分为4个部分：第1部分为绪言，第三世界部分为方法，第3部分为执行纲要，第4部分为证据基础。本译文仅译出了前三部分。原文中有大量表格，译文中从略——译者注
AACE指南.doc

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1682116, encodeId=25ea168211681, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Sun Jan 20 08:53:00 CST 2013, time=2013-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797289, encodeId=fcd01e972895a, content=<a href='/topic/show?id=f044226884f' target=_blank style='color:#2F92EE;'>#临床内分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22688, encryptionId=f044226884f, topicName=临床内分泌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8346212, createdName=respect, createdTime=Fri Mar 08 23:53:00 CST 2013, time=2013-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774533, encodeId=83501e745334a, content=<a href='/topic/show?id=daa989924da' target=_blank style='color:#2F92EE;'>#血脂异常管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89924, encryptionId=daa989924da, topicName=血脂异常管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Mon Dec 03 05:53:00 CST 2012, time=2012-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944326, encodeId=62aa1944326c9, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Tue Aug 21 15:53:00 CST 2012, time=2012-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1253693, encodeId=afd712536932b, content=<a href='/topic/show?id=cbd48992056' target=_blank style='color:#2F92EE;'>#血脂异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89920, encryptionId=cbd48992056, topicName=血脂异常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Sat Mar 31 06:53:00 CST 2012, time=2012-03-31, status=1, ipAttribution=)]
    2013-01-20 gwc392

    #分泌#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1682116, encodeId=25ea168211681, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Sun Jan 20 08:53:00 CST 2013, time=2013-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797289, encodeId=fcd01e972895a, content=<a href='/topic/show?id=f044226884f' target=_blank style='color:#2F92EE;'>#临床内分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22688, encryptionId=f044226884f, topicName=临床内分泌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8346212, createdName=respect, createdTime=Fri Mar 08 23:53:00 CST 2013, time=2013-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774533, encodeId=83501e745334a, content=<a href='/topic/show?id=daa989924da' target=_blank style='color:#2F92EE;'>#血脂异常管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89924, encryptionId=daa989924da, topicName=血脂异常管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Mon Dec 03 05:53:00 CST 2012, time=2012-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944326, encodeId=62aa1944326c9, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Tue Aug 21 15:53:00 CST 2012, time=2012-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1253693, encodeId=afd712536932b, content=<a href='/topic/show?id=cbd48992056' target=_blank style='color:#2F92EE;'>#血脂异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89920, encryptionId=cbd48992056, topicName=血脂异常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Sat Mar 31 06:53:00 CST 2012, time=2012-03-31, status=1, ipAttribution=)]
    2013-03-08 respect

    #临床内分泌#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1682116, encodeId=25ea168211681, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Sun Jan 20 08:53:00 CST 2013, time=2013-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797289, encodeId=fcd01e972895a, content=<a href='/topic/show?id=f044226884f' target=_blank style='color:#2F92EE;'>#临床内分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22688, encryptionId=f044226884f, topicName=临床内分泌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8346212, createdName=respect, createdTime=Fri Mar 08 23:53:00 CST 2013, time=2013-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774533, encodeId=83501e745334a, content=<a href='/topic/show?id=daa989924da' target=_blank style='color:#2F92EE;'>#血脂异常管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89924, encryptionId=daa989924da, topicName=血脂异常管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Mon Dec 03 05:53:00 CST 2012, time=2012-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944326, encodeId=62aa1944326c9, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Tue Aug 21 15:53:00 CST 2012, time=2012-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1253693, encodeId=afd712536932b, content=<a href='/topic/show?id=cbd48992056' target=_blank style='color:#2F92EE;'>#血脂异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89920, encryptionId=cbd48992056, topicName=血脂异常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Sat Mar 31 06:53:00 CST 2012, time=2012-03-31, status=1, ipAttribution=)]
    2012-12-03 xugumin

    #血脂异常管理#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1682116, encodeId=25ea168211681, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Sun Jan 20 08:53:00 CST 2013, time=2013-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797289, encodeId=fcd01e972895a, content=<a href='/topic/show?id=f044226884f' target=_blank style='color:#2F92EE;'>#临床内分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22688, encryptionId=f044226884f, topicName=临床内分泌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8346212, createdName=respect, createdTime=Fri Mar 08 23:53:00 CST 2013, time=2013-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774533, encodeId=83501e745334a, content=<a href='/topic/show?id=daa989924da' target=_blank style='color:#2F92EE;'>#血脂异常管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89924, encryptionId=daa989924da, topicName=血脂异常管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Mon Dec 03 05:53:00 CST 2012, time=2012-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944326, encodeId=62aa1944326c9, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Tue Aug 21 15:53:00 CST 2012, time=2012-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1253693, encodeId=afd712536932b, content=<a href='/topic/show?id=cbd48992056' target=_blank style='color:#2F92EE;'>#血脂异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89920, encryptionId=cbd48992056, topicName=血脂异常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Sat Mar 31 06:53:00 CST 2012, time=2012-03-31, status=1, ipAttribution=)]
    2012-08-21 huangshifeng

    #粥样硬化#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1682116, encodeId=25ea168211681, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Sun Jan 20 08:53:00 CST 2013, time=2013-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797289, encodeId=fcd01e972895a, content=<a href='/topic/show?id=f044226884f' target=_blank style='color:#2F92EE;'>#临床内分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22688, encryptionId=f044226884f, topicName=临床内分泌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8346212, createdName=respect, createdTime=Fri Mar 08 23:53:00 CST 2013, time=2013-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774533, encodeId=83501e745334a, content=<a href='/topic/show?id=daa989924da' target=_blank style='color:#2F92EE;'>#血脂异常管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89924, encryptionId=daa989924da, topicName=血脂异常管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Mon Dec 03 05:53:00 CST 2012, time=2012-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944326, encodeId=62aa1944326c9, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Tue Aug 21 15:53:00 CST 2012, time=2012-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1253693, encodeId=afd712536932b, content=<a href='/topic/show?id=cbd48992056' target=_blank style='color:#2F92EE;'>#血脂异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89920, encryptionId=cbd48992056, topicName=血脂异常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Sat Mar 31 06:53:00 CST 2012, time=2012-03-31, status=1, ipAttribution=)]
    2012-03-31 bugit

    #血脂异常#

    0

相关资讯

庄辉：2012版APASL慢性乙型肝炎诊疗指南更新要点

　　 　　表1 指南推荐意见5 　　 　　表2 指南推荐意见6 　　 　　表3 指南推荐意见9 　　 　　自2008年版亚太肝脏研究学会（APASL）慢性乙型肝炎（CHB）诊疗指南（《亚太地区慢性乙型肝炎管理共识：2008更新》 Hepatol Int 2008,2:263）发表以来，抗乙型肝炎病毒 （HBV）新药如替诺福韦（TDF）等在全球上

NCCN直肠癌诊治指南更新要点

　　北京大学第三医院普通外科姚宏伟和北京大学第一医院普通外科刘荫华就最新发布的2012年第1版美国国立综合癌症网（NCCN）直肠癌指南，以及近5年来NCCN指南（中国版）更新重点来分析探讨直肠癌个体化诊治进步历程。该论文发表在2012年第3期《中华外科杂志》。医学论坛网编辑对此整理如下： 　　直肠癌定位及分期诊断： 　　1. 定位诊断更加明确：2007年NCCN指南首次将直肠癌明确定义为“直肠

ACG颁布《溃疡出血患者处理指南》

　溃疡是上消化道出血（UGIB）住院的最常见原因，而且绝大多数有关非静脉曲张性UGIB治疗的临床试验都聚焦在溃疡病上。近日，美国胃肠病学会（ACG）颁布了《溃疡出血患者处理指南》，该指南为有显性上消化道出血的患者提供了递进式（step-wise）的推荐意见，并就溃疡出血患者的危险评估、内镜检查前药物治疗、洗胃、内镜检查时机、内镜诊断、内镜治疗、内镜检查后药物治疗、复查内镜、住院标准、溃疡再出血的长

新版APASL《丙型肝炎病毒感染共识和治疗程序》发布

    在亚太肝脏研究学会（APASL）第22届年会上，除了更新版《亚太地区慢性乙型肝炎管理共识》（草案）发布，还有另一引人注目的指南更新——《APASL Consensus Statements and Management Algorithms for Hepatitis C Virus Infection》，即：2012版亚太地区《丙型肝炎病毒感染共识和治疗程序

美国妇产科医师协会(ACOG) 发布乳腺癌治疗指南

美国妇产科医师协会(ACOG) 2月21日在线发布了有关正在接受或已经接受乳腺癌治疗者的妇科疾病诊治最新临床指南，并指出选择性5-羟色胺再摄取抑制剂(SSRI)可安全用于治疗部分乳腺癌女性患者的潮热症状，且不会增加乳腺癌治疗期间怀孕女性的疾病复发风险(Obstet. Gynecol. 2012;119:666-82)。 新指南引用了166篇已发表的文献证据，涵盖了化疗、激素治疗、放疗和手术治疗等

AAO临床指南：遗传性眼病基因检测推荐（2012年）

推荐规范指出，新的眼疾基因测试板能够提高诊断与预后的准确性，也能帮助确诊前的个体，这些个体常需要预防治疗或常需监测早期迹象及可治疗症状。 基因检测亦可使医生能提供以机制为基础的护理，这对区别那些具有基因亚型的疾病尤为重要，如视网膜色素变性（RP）和莱伯先天性黑朦亚型。 推荐规范为执行基因检测建立了5大步骤：临场适应症已知的遗传性眼疾、DNA样本来自渊源者或家庭成员、分析结果、在患者的呈报中